Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Intellia Therapeutics, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 9:00 a.m. PT, highlighting its focus on CRISPR-based therapies [1] - The company is recognized as a leading clinical-stage gene editing firm, aiming to revolutionize medicine through innovative gene editing technologies [3] Company Overview - Intellia Therapeutics specializes in developing first-in-class medicines that address significant unmet medical needs, leveraging its expertise in gene editing [3] - The company is committed to advancing the treatment paradigm for patients by expanding its CRISPR-based platform with novel editing and delivery technologies [3] Investor Information - A live webcast of the presentation will be available on Intellia's website, with a replay accessible for approximately 30 days [2]